@lost
Still thinking about this in-specie question.
PAC is probably in a rather common situation : a group where the sum of the parts is higher than the market cap.
So, it is interesting to see how most of the groups deal with this question.
I think it is quite rare that they use the "in-specie" solution.
My experience is more than companies decide to do a spin-off to let the market decide what's the real value of the interesting asset.
PAC' situation today is quite similar : the listing of GQG should let the market decide what's the value of this asset.
So, if GQG listing go through and the market values it as we expect, I don't see any reason why it would not be reflected at the end in PAC's market cap.
Of course, at this stage, there may be still be a large discount for PAC vs its sum of the parts.
In that case, it would make sense to think about "in specie".
But, now, it looks a bit early to me.
- Forums
- Lounge
- Fund managers
Fund managers, page-78
- There are more pages in this discussion • 1,327 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)